Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamilla Østergaard

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|May 12, 2012
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register dataKamilla Østergaard, Jesper Hallas, Søren Bak, et al.
European Journal of Clinical Pharmacology|November 20, 2013
Long-term use of antiplatelet drugs by patients with transient ischaemic attackKamilla Østergaard, Charlotte Madsen, Marie-Louise Liu, et al.
Acta Neuropathologica Communications|June 7, 2020
Characterization of the TNF and IL-1 systems in human brain and blood after ischemic strokeBettina H Clausen, Martin Wirenfeldt, Sofie S Høgedal, et al.
Journal of Neuroinflammation|July 21, 2014
No effect of ablation of surfactant protein-D on acute cerebral infarction in miceKate L Lambertsen, Kamilla Østergaard, Bettina H Clausen, et al.
Brain : a Journal of Neurology|May 19, 2016
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI studyDavid Gaist, Ellen Garde, Morten Blaabjerg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Extended interval dosing with ocrelizumab in multiple sclerosisFrederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.
Brain : a Journal of Neurology|January 24, 2018
Migraine with visual aura associated with thicker visual cortexDavid Gaist, Anders Hougaard, Ellen Garde, et al.
Multiple Sclerosis and Related Disorders|March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patientsHamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
Neuroimage. Clinical|August 9, 2020
Migraine with aura in women is not associated with structural thalamic abnormalitiesAnders Hougaard, Silas Haahr Nielsen, David Gaist, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|May 12, 2012
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register dataKamilla Østergaard, Jesper Hallas, Søren Bak, et al.
European Journal of Clinical Pharmacology|November 20, 2013
Long-term use of antiplatelet drugs by patients with transient ischaemic attackKamilla Østergaard, Charlotte Madsen, Marie-Louise Liu, et al.
Acta Neuropathologica Communications|June 7, 2020
Characterization of the TNF and IL-1 systems in human brain and blood after ischemic strokeBettina H Clausen, Martin Wirenfeldt, Sofie S Høgedal, et al.
Journal of Neuroinflammation|July 21, 2014
No effect of ablation of surfactant protein-D on acute cerebral infarction in miceKate L Lambertsen, Kamilla Østergaard, Bettina H Clausen, et al.
Brain : a Journal of Neurology|May 19, 2016
Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI studyDavid Gaist, Ellen Garde, Morten Blaabjerg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2024
Extended interval dosing with ocrelizumab in multiple sclerosisFrederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard, et al.
Brain : a Journal of Neurology|January 24, 2018
Migraine with visual aura associated with thicker visual cortexDavid Gaist, Anders Hougaard, Ellen Garde, et al.
Multiple Sclerosis and Related Disorders|March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patientsHamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
Neuroimage. Clinical|August 9, 2020
Migraine with aura in women is not associated with structural thalamic abnormalitiesAnders Hougaard, Silas Haahr Nielsen, David Gaist, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Pageof 2